Preliminary clinical experience of trans-1-amino-3-(18)F- fluorocyclobutanecarboxylic acid (anti-(18)F-FACBC) PET/CT imaging in prostate cancer patients

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Kairemo, Kalevi ^a   Rasulova, Nigora ^a   Partanen, Kaarina ^a   Joensuu, Timo ^a  

^a Docrates Oncology Clinic   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; DENOSUMAB; FLUCICLOVINE F 18; LEXIDRONAM SAMARIUM SM 153; PROSTATE SPECIFIC ANTIGEN; SODIUM FLUORIDE F 18; 1-AMINO-3-FLUOROCYCLOBUTANE-1-CARBOXYLIC ACID; CARBOXYLIC ACID; CYCLOBUTANE DERIVATIVE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BRAIN; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG UPTAKE; HUMAN; LABORATORY TEST; LYMPH NODE; LYMPH NODE METASTASIS; MALE; MENINGIOMA; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PET-CT SCANNER; PROSTATE CANCER; PROSTATECTOMY; PROTEIN BLOOD LEVEL; PSA DOUBLING TIME; RADIOISOTOPE THERAPY; RETROSPECTIVE STUDY; SEMINAL VESICLE; TIME; DIAGNOSTIC IMAGING; DIAGNOSTIC USE; ISOLATION AND PURIFICATION; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROSTATE TUMOR; RADIOGRAPHY; TUMOR RECURRENCE;

AGED; CARBOXYLIC ACIDS; CYCLOBUTANES; DIAGNOSTIC IMAGING; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS;

EID: 84903617812     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/305182     Document Type: Article

References (15)

1. Nye J. A., Schuster D. M., Yu W., Camp V. M., Goodman M. M., Votaw J. R., Biodistribution and radiation dosimetry of the synthetic nonmetabolized amino acid analogue anti- 18F-FACBC in humans. Journal of Nuclear Medicine 2007 48 6 1017 1020 2-s2.0-34250323369 10.2967/jnumed.107.040097 (Pubitemid 46909932)
2. Sörensen J., Owenius R., Lax M., Johansson S., Regional distribution and kinetics of [18F]fluciclovine (anti-[18F]FACBC), a tracer of amino acid transport, in subjects with primary prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging 2013 40 3 394 402 2-s2.0-84873995044 10.1007/s00259-012-2291-9
3. Schuster D. M., Taleghani P. A., Nieh P. T., Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake. The American Journal of Nuclear Medicine and Molecular 2013 3 1 85 96
4. Amzat R., Taleghani P., Miller D. L., Beitler J. J., Bellamy L. M., Nye J. A., Yu W., Savir-Baruch B., Osunkoya A. O., Chen Z., Auffermann W. F., Goodman M. M., Schuster D. M., Pilot study of the utility of the synthetic PET amino-acid radiotracer anti-1-amino-3-[18F]fluorocyclobutane-1-carboxylic acid for the noninvasive imaging of pulmonary lesions. Molecular Imaging and Biology 2013 15 5 633 643 2-s2.0-84876074486 10.1007/s11307-012-0606-7
5. Schuster D. M., Savir-Baruch B., Nieh P. T., Master V. A., Halkar R. K., Rossi P. J., Lewis M. M., Nye J. A., Yu W., Bowman F. D., Goodman M. M., Detection of recurrent prostate carcinoma with anti-1-amino-3- 18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT. Radiology 2011 259 3 852 861 2-s2.0-79956327484 10.1148/radiol. 11102023
6. Nanni C., Schiavina R., Boschi S., Ambrosini V., Pettinato C., Brunocilla E., Martorana G., Fanti S., Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results. European Journal of Nuclear Medicine and Molecular Imaging 2013 40 supplement 1 S11 S17 2-s2.0-84876126374 10.1007/s00259-013-2373-3
7. Nanni C., Schiavina R., Brunocilla E., Borghesi M., Ambrosini V., Zanoni L., Gentile G., Vagnoni V., Romagnoli D., Martorana G., Fanti S., 18F-FACBC compared with 11C-Choline PET/CT in patients with biochemical relapse after radical prostatectomy: a prospective study in 28 patients. Clinical Genitourinary Cancer 2014 12 2 106 110 10.1016/j.clgc.2013.08.002
8. Oka S., Hattori R., Kurosaki F., Toyama M., Williams L. A., Yu W., Votaw J. R., Yoshida Y., Goodman M. M., Ito O., A preliminary study of anti-1-amino-3-18f-fluorocyclobutyl-1- carboxylic acid for the detection of prostate cancer. Journal of Nuclear Medicine 2007 48 1 46 55 2-s2.0-33847309910 (Pubitemid 47555375)
9. von Eyben F. E., Kairemo K., Meta-analysis of 11C-choline and 18F-choline PET/CT for management of patients with prostate cancer. Nuclear Medicine Communications 2014 35 3 221 230
10. Okudaira H., Shikano N., Nishii R., Miyagi T., Yoshimoto M., Kobayashi M., Ohe K., Nakanishi T., Tamai I., Namiki M., Kawai K., Putative transport mechanism and intracellular fate of trans-1-amino-3-18F- fluorocyclobutanecarboxylic acid in human prostate cancer. Journal of Nuclear Medicine 2011 52 5 822 829 2-s2.0-79955775731 10.2967/jnumed.110.086074
11. Castellucci P., Jadvar H., PET/CT in prostate cancer: Non-choline radiopharmaceuticals. Quarterly Journal of Nuclear Medicine and Molecular Imaging 2012 56 4 367 374 2-s2.0-84869826267
12. Ceci F., Castellucci P., Graziani T., Schiavina R., Brunocilla E., Mazzarotto R., Ntreta M., Lodi F., Martorana G., Fanti S., 11C-Choline PET/CT detects the site of relapse in the majority of prostate cancer patients showing biochemical recurrence after EBRT. European Journal of Nuclear Medicine and Molecular Imaging 2014 41 5 878 886
13. von Eyben F. E., Kangasmäki A., Kiljunen T., Joensuu T., Volumetric-modulated arc therapy for a pelvic lymph node metastasis from prostate cancer: a case report. Tumori 2013 99 3 e120 e123 10.1700/1334.14819
14. Giovacchini G., Picchio M., Garcia-Parra R., Briganti A., Abdollah F., Gianolli L., Schindler C., Montorsi F., Messa C., Fazio F., 11C-Choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy. Journal of Nuclear Medicine 2014 55 2 233 241
15. Beheshti M., Haim S., Zakavi R., Steinmair M., Waldenberger P., Kunit T., Nader M., Langsteger W., Loid W., Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics. Journal of Nuclear Medicine 2013 54 6 833 840 2-s2.0-84878659527 10.2967/jnumed.112.110148